Skip to main content
Clinical Trials/NCT02800434
NCT02800434CompletedNot Applicable

Clinical Evaluation of Bilateral Hand Allograft: Pilot Study of 7 Cases

Hospices Civils de Lyon2 sites in 1 country7 target enrollmentStarted: January 1, 2000Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
7
Locations
2
Primary Endpoint
fMRI for evaluation of brain plasticity after transplant

Study Overview

Brief Summary

The double amputation of the forearms is a rare handicap that seriously impacts the autonomy and the quality of life of patients, social and familial exclusion, and dependence on third parties for everyday activities.

The management of these patients is nearly exclusively through the use of prostheses. Certain patients refuse this solution, or remain penalized by the absence of sensation, the lack of precision in movements, and body image issues related to the amputation; the double graft of hands and forearms may, in this circumstance, be the only solution.

The objective of this pilot study was designed to evaluate the cerebral plasticity of patients who undergo bilateral hand allograph

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • double amputated patients
  • minimum of 3 months and maximum of 3 years interval between amputation and graft
  • adult aged 20 to 40 years
  • psychological maturity
  • written informed consent

Exclusion Criteria

  • mono amputated patients
  • previous history of malignant tumor in remission for less than 5 years,
  • malignant tumor
  • previous psychiatric history
  • American Society of Anesthesiology (ASA) score >2
  • New York Heart Association (NYHA) >1
  • nenal insufficiency
  • severe hypertension

Outcomes

Primary Outcomes

fMRI for evaluation of brain plasticity after transplant

Time Frame: 1 year

Evaluation of brain plasticity after transplant

Secondary Outcomes

  • Adverse events(5 years)
  • Rejection(Every 6 months following graft up to 5 years)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials